Reversing Tumor Immune Suppression with Intratumoral IL-12: Activation of Tumor-Associated T Effector/Memory Cells, Induction of T Suppressor Apoptosis, and Infiltration of CD8+T Effectors-Reference-Cited by-同舟云学术

Reversing Tumor Immune Suppression with Intratumoral IL-12: Activation of Tumor-Associated T Effector/Memory Cells, Induction of T Suppressor Apoptosis, and Infiltration of CD8+T Effectors

Published:2006-11-02 Issue:10 Volume:177 Page:6962-6973
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Kilinc Mehmet O.,Aulakh Karanvir S.,Nair Raji E.,Jones Stacy A.,Alard Pascale,Kosiewicz Michele M.,Egilmez Nejat K.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference48 articles.

1. Progress and controversies in developing cancer vaccines

2. Recent developments in therapeutic cancer vaccines

3. Cancer immunotherapy: moving beyond current vaccines

4. MONITORING IMMUNE RESPONSES IN CANCER PATIENTS RECEIVING TUMOR VACCINES

5. Active-specific immunization against melanoma: Is the problem at the receiving end?

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Memory inflation: Beyond the acute phase of viral infection;Cell Proliferation;2024-07-11

2. Synergistic antitumor immune response mediated by paclitaxel-conjugated nanohybrid oncolytic adenovirus with dendritic cell therapy;Frontiers in Immunology;2024-05-21

3. Noncovalently particle-anchored cytokines with prolonged tumor retention safely elicit potent antitumor immunity;Science Advances;2024-04-19

4. Vector Aided Microenvironment programming (VAMP): reprogramming the TME with MVA virus expressing IL-12 for effective antitumor activity;Journal for ImmunoTherapy of Cancer;2023-04

5. Analysis of causes for poor persistence of CAR-T cell therapy in vivo;Frontiers in Immunology;2023-01-25